Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News 9342-8530 Quebec Inc DGCRF

Healthcare Biotechnology
Diagnocure Inc is a Canada based biotechnology company. It is primarily engaged in the business activity of development and commercialization of products relating to the diagnosis of cancer. The group generates its revenue from research and license agreement. The head office of the company is located in Quebec, Canada.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (GREY:DGCRF)

Mid-Afternoon Market Update: NASDAQ Down 1%; LendingTree Shares Spike Higher

Benzinga.com  July 27, 2017

Mid-Afternoon Market Update: Crude Oil Up 3%; Seagate Shares Drop After Q4 Miss

Benzinga.com  July 25, 2017

20 Biggest Mid-Day Losers For Tuesday

Benzinga.com  July 25, 2017

Mid-Day Market Update: Dow Rises Over 100 Points; Team Shares Plummet

Benzinga.com  July 25, 2017

DiagnoCure announces results of its Annual and Special Meeting of shareholders

Canada NewsWire May 19, 2016

IIROC Trade Resumption - DiagnoCure Inc.

Newsfile April 15, 2016

IIROC Trade Resumption - CUR

Canada NewsWire April 15, 2016

Diagnocure announces its decision to proceed with the voluntary Liquidation and Dissolution of the Corporation

Canada NewsWire April 15, 2016

IIROC Trade Halt - DiagnoCure Inc.

Newsfile April 15, 2016
View More News ››

Opinion & Analysis (GREY:DGCRF)

No current opinion is available.
View More Opinion ››

Bullboard Posts (GREY:DGCRF)

What now?

Excuse my ignorance, but does anyone know what we should be expecting going forward? My trading account still shows that I have shares in...
so_wrong - June 13, 2016

RE:While yur still bent over....

I don't evaluate an early stage biotech on the banal metrics of last year's revenues, ebidat, loss, etc.. but for what it has in...
Dibah42 - April 24, 2016

While yur still bent over....

Dibbah would like you to push the pump on this PLI company with a 2 BILLION, yeah 2 BILLION market cap and 24M in revenue with a 56 M...
somweyungguy - April 23, 2016

Adieu or au revoir

I would like to thank all you gentlemen (and ladies) for your contribution to this bb.  It has been a long decade-plus of interest...
Dibah42 - April 23, 2016

RE:RE:what will we receive?

less than .01 any sale at a penny or better in my view is right
oceanblvd - April 19, 2016

R.I.P.

Amen
Dibah42 - April 18, 2016
View more Bullboard ››

Tidal Care Inc.

Tidal Care Inc.

Tidal Care aims to be a high-compliance supplier of finished, formulated Psilocybin- and MDMA-based drug products to the ...
View More »